An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Investigational Drug Gaining Traction Online
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing trade exists on messaging services, where communities with thousands of members share comparison images, injection guides and assertions of next-day UK delivery. Sellers market the drug there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Express Worries
However, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in users administering substances of uncertain source.
Some experts said the popularity for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.
Several content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, risking fines, prosecution or prison.
Platform Reaction and Content Removal
Based on TikTok, the platform has removed violative material and prohibited associated hashtags and query recommendations. The company stated it was dedicated to keeping the service safe and investing in strengthening compliance measures.
Digital Marketplace Activities
Investigations also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with images of slimming results, glowing testimonials and step-by-step guides for preparing or administering at home.
After minutes of joining one community, a seller shared contact information, where the majority of transactions take place. The vendor provided an guidebook and promised shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Item Details and Pricing
Inside these groups, messages display dark colored packages with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give conflicting responses varying between a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service stated it regularly moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting substances they can’t verify. Even if the science behind this drug is sound, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of an online medical service linked the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has already encountered individuals harmed by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to potentially significant medical dangers”.
